![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EMA Urges Sponsors to Submit Minor Marketing Authorization Changes by March 29
EMA Urges Sponsors to Submit Minor Marketing Authorization Changes by March 29
![EMA_Logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images3/EMA_Logo.gif?t=1579219264&width=430)
The EMA called on drug sponsors to prepare for a surge in minor marketing authorization change submissions in the next three months as companies prepare for the UK’s scheduled exit from the EU on March 29.
To avoid a pileup of submissions on Brexit day, sponsors should file minor Brexit-related variations well in advance of March 29 so that marketing authorization holders can confirm their compliance with regulatory and legal requirements before the UK’s exit.
The agency foresees a significant increase — over 50 percent — in the number of Type I variations in the next three months as companies submit Brexit-related changes to their marketing authorizations.
Upcoming Events
-
21Oct